We further confirmed this finding in our clinical samples and found elevated levels of the IGF2BP1 protein in BC tissues compared with paired normal breast tissues by immunohistochemical (IHC) staining (n=11; Figure 1G). Here, IGF2BP1 is linked to breast cancer.